Helen Collins, based in South San Francisco, CA, US, is currently a Chief Medical Officer at Enliven Therapeutics, bringing experience from previous roles at Five Prime Therapeutics, Inc., Gilead Sciences and Amgen. Helen Collins holds a 1992 - 1995 Fellowship in Medical oncology @ Stanford University. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Clinical Research, Medical Affairs, Cancer and more, Helen Collins contributes valuable insights to the industry. Helen Collins has 2 emails and 1 mobile phone number on RocketReach.